CTCara Taheny

Cara Taheny

*This is an algorithmically generated author record based on publicly available information.

Cara Taheny has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Priorities to eliminate congenital syphilis in Australia: findings from a national roundtable

    by Alexandra Lipa, Jessica Michaels, James Ward, Judith Dean, Manoji Gunathilake, Lucy Stackpool-Moore, Megan Campbell, Diane Rowling, Nathan Ryder, Catriona Ooi, et al.

    Congenital syphilis remains a significant public health threat in Australia, warranting national efforts to reduce syphilis incidence overall, focusing on women of reproductive age. To identify priority actions to eliminate congenital syphilis, ASHM convened a national multidisciplinary roundtable with attendance from organisations, colleges, and bodies across the healthcare sector with a focus on Aboriginal and Torres Strait Islander peoples’ health, sexual and reproductive health, antenatal health, primary care, pathology, and pharmacy, as well as research institutes and community organisations. This position statement outlines the immediate, short-term and long-term actions identified by roundtable participants to eliminate congenital syphilis in Australia.

  • Strategies to achieve the UNAIDS 95% HIV diagnosis target in Australia: Insights from a multidisciplinary roundtable

    by Brent Clifton, Phillip Keen, Janine Trevillyan, Nikki Sullivan, Karl Johnson, Melissa Warner, Cara Taheny, Heather Ellis, Jack Freestone, Brent Allan, et al.

    Introduction: In 2022, Australia met the global UNAIDS 95% targets for treatment and viral suppression. Achieving 95% of people knowing their HIV status requires implementation of a wider mix of HIV testing types and access points.Methods: In October 2023, a community‐led HIV testing roundtable meeting of 34 participants was convened to better understand current barriers and enablers to foster HIV testing equity. Delegates participated in data‐informed discussions and a facilitated workshop. Outputs were collated and independently analysed to identify HIV testing barriers and potential actionable strategies.Results: Current best practices for HIV testing are targeted towards at‐risk populations and limited by funding and capacity constraints. Identified barriers to testing include ongoing stigma, cultural barriers, structural barriers to accessing and navigating the healthcare system, clinical reticence among non‐expert practitioners and the need to expand access beyond at‐risk groups. Current HIV testing practices are limited by a lack of provider‐initiated (opt‐out) testing, contributing to late diagnoses among people with high barriers to testing. Awareness of and access to HIV testing resources need to be expanded and should be underpinned by healthcare education. Wider exploration of opt‐out testing is warranted, but requires consideration of jurisdictional infrastructure/funding differences and determination of optimal settings.Conclusions: To achieve the UNAIDS 95% diagnosis target, we recommend three key strategies: implementing opt‐out testing in selected settings, expanding access to self‐testing and reducing barriers to point of care testing. These strategies should be supported by enhanced healthcare provider education and actions to reduce structural barriers to testing access.